Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|
February 2, 2012
Hospital-physician alignment: making the relationship work
Kate Lovrien, Luke Peterson
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
March 3, 2006
Crystallization of truncated hemolysin A from Proteus mirabilis
Luke Bailey, Sean Agger, Luke Peterson, et al.
Expert Opinion on Drug Delivery
|
November 2, 2016
Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis
Barbara Domańska, Brenda VanLunen, Luke Peterson, et al.
The Journal of Rheumatology
|
May 3, 2018
PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol
Jessica A Walsh, Terri Arledge, Tommi Nurminen, et al.
World Journal of Psychiatry
|
January 24, 2022
Mechanism of olfactory deficit in neurotrauma and its related affective distress: A narrative review
Mark Logan, Siddharth Kapoor, Luke Peterson, et al.
Dermatology and Therapy
|
August 27, 2020
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
Alice B Gottlieb, Valerie Ciaravino, Christopher Cioffi, et al.
Journal of Drugs in Dermatology : JDD
|
February 8, 2022
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis
Jerry Bagel, Daljit Tatla, Scarlett Hellot, et al.
Dermatology and Therapy
|
March 28, 2025
Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data
John R Ingram, Jérémy Lambert, Valerie Ciaravino, et al.
Advances in Therapy
|
September 2, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial
Alice B Gottlieb, Richard B Warren, Matthias Augustin, et al.
Dermatology and Therapy
|
July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials
Richard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Healthcare Financial Management : Journal of the Healthcare Financial Management Association
|
February 2, 2012
Hospital-physician alignment: making the relationship work
Kate Lovrien, Luke Peterson
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
March 3, 2006
Crystallization of truncated hemolysin A from Proteus mirabilis
Luke Bailey, Sean Agger, Luke Peterson, et al.
Expert Opinion on Drug Delivery
|
November 2, 2016
Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis
Barbara Domańska, Brenda VanLunen, Luke Peterson, et al.
The Journal of Rheumatology
|
May 3, 2018
PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol
Jessica A Walsh, Terri Arledge, Tommi Nurminen, et al.
World Journal of Psychiatry
|
January 24, 2022
Mechanism of olfactory deficit in neurotrauma and its related affective distress: A narrative review
Mark Logan, Siddharth Kapoor, Luke Peterson, et al.
Dermatology and Therapy
|
August 27, 2020
Development and Content Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM) for Assessment of Plaque Psoriasis
Alice B Gottlieb, Valerie Ciaravino, Christopher Cioffi, et al.
Journal of Drugs in Dermatology : JDD
|
February 8, 2022
Bimekizumab Self-Injection Devices: Two Multicenter, Randomized, Open-Label Studies on Self-Administration by Patients With Psoriasis
Jerry Bagel, Daljit Tatla, Scarlett Hellot, et al.
Dermatology and Therapy
|
March 28, 2025
Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data
John R Ingram, Jérémy Lambert, Valerie Ciaravino, et al.
Advances in Therapy
|
September 2, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM): A Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Reported Data from the BE RADIANT Phase 3b Trial
Alice B Gottlieb, Richard B Warren, Matthias Augustin, et al.
Dermatology and Therapy
|
July 14, 2021
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials
Richard B Warren, Alice B Gottlieb, Joseph F Merola, et al.
Page
of 3